XML 62 R7.htm IDEA: XBRL DOCUMENT v3.19.3
REVENUE RECOGNITION Revenue Recognition (Notes)
9 Months Ended
Sep. 30, 2019
Revenue Recognition [Abstract]  
Revenue from Contract with Customer [Text Block] REVENUE

The following table summarizes the disaggregation of revenue by nature:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Dollars in Millions
2019
 
2018
 
2019
 
2018
Net product sales
$
5,768

 
$
5,433

 
$
17,512

 
$
15,866

Alliance revenues
143

 
177

 
418

 
483

Other revenues
96

 
81

 
270

 
239

Total Revenues
$
6,007

 
$
5,691

 
$
18,200

 
$
16,588



The following table summarizes GTN adjustments:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Dollars in Millions
2019
 
2018
 
2019
 
2018
Gross product sales
$
8,884

 
$
7,681

 
$
25,697

 
$
21,891

GTN adjustments(a)
 
 
 
 
 
 
 
Charge-backs and cash discounts
(927
)
 
(711
)
 
(2,591
)
 
(1,957
)
Medicaid and Medicare rebates
(1,362
)
 
(847
)
 
(3,252
)
 
(2,169
)
Other rebates, returns, discounts and adjustments
(827
)
 
(690
)
 
(2,342
)
 
(1,899
)
Total GTN adjustments
(3,116
)
 
(2,248
)
 
(8,185
)
 
(6,025
)
Net product sales
$
5,768

 
$
5,433

 
$
17,512

 
$
15,866


(a)
Includes adjustments to provisions for product sales made in prior periods resulting from changes in estimates of $12 million and $139 million for the three and nine months ended September 30, 2019 and $(7) million and $103 million for the three and nine months ended September 30, 2018, respectively.

The following table summarizes the disaggregation of revenue by product and region:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Dollars in Millions
2019
 
2018
 
2019
 
2018
Prioritized Brands
 
 
 
 
 
 
 
Opdivo
$
1,817

 
$
1,793

 
$
5,441

 
$
4,931

Eliquis
1,928

 
1,577

 
5,895

 
4,733

Orencia
767

 
675

 
2,185

 
1,979

Sprycel
558

 
491

 
1,561

 
1,464

Yervoy
353

 
382

 
1,104

 
946

Empliciti
89

 
59

 
263

 
178

 
 
 
 
 
 
 
 
Established Brands

 

 
 
 
 
Baraclude
145

 
175

 
433

 
579

Other Brands
350

 
539

 
1,318

 
1,778

Total Revenues
$
6,007

 
$
5,691

 
$
18,200

 
$
16,588

 
 
 
 
 
 
 
 
United States
$
3,472

 
$
3,235

 
$
10,588

 
$
9,243

Europe
1,445

 
1,365

 
4,416

 
4,179

Rest of the World
976

 
932

 
2,838

 
2,728

Other(a)
114

 
159

 
358

 
438

Total Revenues
$
6,007

 
$
5,691

 
$
18,200

 
$
16,588


(a)
Other revenues include royalties and alliance-related revenues for products not sold by the Company's regional commercial organizations.
Revenue recognized from performance obligations satisfied in prior periods was $78 million and $341 million for the three and nine months ended September 30, 2019 and $97 million and $398 million for the three and nine months ended September 30, 2018, respectively, consisting primarily of royalties for out-licensing arrangements and revised estimates for gross-to-net adjustments related to prior period sales. Contract assets were not material at September 30, 2019 and December 31, 2018.